Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show
Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why.
Express News | UBS Maintains Neutral on Amgen, Lowers Price Target to $315
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data
Express News | RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $320
Amgen | 10-Q: Q1 2025 Earnings Report
Amgen Analyst Ratings
Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
Cantor Fitzgerald Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $305
UBS Maintains Amgen(AMGN.US) With Hold Rating, Cuts Target Price to $315
Research Alert: CFRA Retains Buy Opinion On Shares Of Amgen Inc.
New Analyst Forecast: $AMGN Given 'Equal-Weight' Rating
Amgen Unusual Options Activity For May 02
Citigroup Adjusts Price Target on Amgen to $300 From $290
4 Stocks to Watch on Friday: XOM, CVX, AMGN and TTWO
A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $320 to $389
Cantor Fitzgerald Sticks to Its Hold Rating for Amgen (AMGN)
UBS Adjusts Price Target on Amgen to $315 From $319, Maintains Neutral Rating
RBC Capital Keeps Their Buy Rating on Amgen (AMGN)
Express News | Amgen Inc : RBC Cuts Target Price to $320 From $324